UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-02-08 Future report Set alerts
Q3 2020 2020-10-26 Future report Set alerts
Q2 2020 2020-07-30 0.38 -0.31
Q1 2020 2020-05-05 -0.34 -1.20
Q4 2019 2020-02-11 0.47 -1.60
Q3 2019 2019-10-29 -0.06 -0.46
Q2 2019 2019-07-25 0.06 -0.66
Q1 2019 2019-04-30 -0.63 -1.74
Q4 2018 2019-02-13 -0.08 -1.62
Q3 2018 2018-10-31 -0.61 -2.65

Ratings

2016-07-05 Reiterated Rating Pacific Crest Sector Weight
2016-05-03 Lower Price Target Imperial Capital In to In-Line $32.00 to $29.00
2016-04-02 Reiterated Rating Imperial Capital Hold
2016-04-01 Lower Price Target Imperial Capital In to In-Line $35.00 to $32.00
2016-02-04 Lower Price Target Wedbush Outperform $46.00 to $40.00
2016-01-25 Upgrade Northcoast Research Neutral to Buy
2015-12-11 Reiterated Rating Wedbush Outperform $46.00
2015-11-23 Boost Price Target Wedbush Outperform $44.00 to $46.00
2015-10-19 Reiterated Rating Wedbush Outperform $40.00 to $44.00
2015-09-18 Reiterated Rating Wedbush Buy $40.00
2015-09-16 Lower Price Target Imperial Capital In to In-Line $39.00 to $35.00
2015-08-31 Upgrade Wedbush Neutral to Outperform $40.00
2015-07-31 Upgrade Wedbush Neutral to Outperform $40.00
2015-07-28 Lower Price Target JPMorgan Chase & Co. Neutral $39.00 to $36.00
2015-07-22 Initiated Coverage Alembic Global Advisors Overweight
2015-06-12 Boost Price Target Wedbush Neutral $36.00 to $40.00
2015-06-04 Upgrade JPMorgan Chase & Co. Underweight to Neutral $33.00 to $39.00
2015-04-07 Boost Price Target KeyBanc Overweight $38.00 to $40.00
2015-04-07 Boost Price Target KeyCorp Overweight $38.00 to $40.00
2014-11-03 Reiterated Rating Imperial Capital In-Line $37.00 to $39.00
2014-03-03 Boost Price Target Wedbush $35.00 to $38.00
2014-02-13 Boost Price Target Susquehanna $27.00 to $30.00
2014-01-17 Boost Price Target Imperial Capital In-Line $33.00 to $35.00
2013-11-18 Upgrade KeyBanc Hold to Buy $35.00
2013-11-14 Lower Price Target Susquehanna Neutral $29.00 to $27.00
2013-10-15 Downgrade Compass Point Neutral to Sell $25.00 to $23.00
2013-07-11 Reiterated Compass Point Neutral $26 to $31
2013-04-30 Reiterated Compass Point Neutral $30 to $26
2013-02-14 Reiterated Imperial Capital Outperform $36 to $35
2013-01-24 Reiterated Compass Point Neutral $33 to $30
2012-06-21 Initiated Imperial Capital Outperform $47
2012-04-24 Upgrade Compass Point Neutral to Buy $40 to $45
2010-11-22 Reiterated Wedbush Neutral $30 to $33
2010-06-29 Reiterated Wedbush Neutral $34 to $30
2010-04-16 Downgrade KeyBanc Capital Mkts Buy to Hold
2016-07-05 Reiterated Rating Pacific Crest Sector Weight
2016-05-03 Lower Price Target Imperial Capital In to In-Line $32.00 to $29.00
2016-04-02 Reiterated Rating Imperial Capital Hold
2016-04-01 Lower Price Target Imperial Capital In to In-Line $35.00 to $32.00
2016-02-04 Lower Price Target Wedbush Outperform $46.00 to $40.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Mattes Andreas W President and CEO 0.32%  (209590) DBD /
SWIDARSKI THOMAS W President & CEO 0.25%  (163054) AIMC / DBD / EFOI / EVTC /
Schmid Gerrard President and CEO 0.18%  (117245) DBD /
Mayes George S JR EVP & Chief Operating Officer 0.12%  (77863) DBD / SRI /
Chapman Christopher A. Vice President, Global Finance 0.11%  (71829) DBD /
FITZGERALD GALE S 0.10%  (61531) CCRN / DBD / HNT /
CRANDALL RICHARD L 0.08%  (53281) DBD / DFIN / RRD /
WALLACE HENRY D G 0.08%  (49114) AMBC / DBD / LEA /
WEBER ALAN J 0.07%  (47942) BR / DBD / SD /
Leiken Jonathan SVP, CLO and Secretary 0.07%  (42521) DBD /
LAUER JOHN N 0.06%  (39048) DBD /
Wunram Jurgen SVP, Chief Integration Officer 0.06%  (37457) DBD /
ALLENDER PATRICK W 0.06%  (36442) BRC / CFX / DBD /
COX PHILLIP R 0.06%  (35642) CBB / DBD / TKR /
KERR ALAN SVP, Software 0.05%  (34387) DBD /
SOIN RAJESH K 0.05%  (33742) DBD /
Rutt Sheila M VP, Chief HR Officer 0.05%  (33023) DBD /
RICHARDSON BRADLEY C EVP & CFO 0.05%  (32741) BRC / DBD / POL / TROX /
GREENFIELD GARY G 0.04%  (26292) AVID / DBD / DFIN / VOCS /
Heyden Olaf Robert SVP, Services 0.04%  (25362) DBD /
Naher Ulrich SVP, Systems 0.04%  (25362) DBD /
Natoli Frank A EVP, Chief Innovation Officer 0.04%  (22629) DBD /
Merz Stefan Sr. VP, Strategic Projects 0.04%  (22627) DBD /
PRATHER ROBERT S JR 0.03%  (20564) DBD / GBL / GTN / RHP /
Kristoff John D VP, Chief Communications Ofcr. 0.03%  (19838) DBD /
Lang Patricia A VP and Chief People Officer 0.03%  (18014) DBD /
BYRNES BRUCE L 0.02%  (16112) BSX / CBB / DBD /
Dusedau Dieter 0.02%  (15092) DBD /
Dibelius Alexander 0.02%  (15092) DBD /
Hunter Matthew Scott VP Treasurer Chief Tax Officer 0.02%  (14853) DBD /
Brown Dean Alexander VP, Corp Strategy & Developmt 0.02%  (11914) DBD /
Hesse Chad F VP General Counsel & Secretary 0.02%  (11190) DBD /
Macey Christopher VP, Corporate Controller 0.02%  (10244) AIT / DBD /
Artavia Roberto 0.01%  (7362) DBD /
Deering Dennis D. VP Global Service & Operations 0.01%  (5501) DBD /

Comments